Legacy MEDSearch

FEBRUARY 28, 2023

RADIANCE II is a randomized, sham-controlled US FDA IDE pivotal trial of the Paradise uRDN System in the treatment of patients with uncontrolled hypertension. Conducted as an international multicenter study at more than 60 study centers in eight countries, 224 patients with uncontrolled hypertension were randomized 2:1 to uRDN or a sham.

Networking 98

Networking Medical Physicians Safety 98

PM360

MARCH 24, 2023

In 2022, SXSW was all NFTs and metaverse activations and events, and in 2023 they weren’t anywhere to be found. Their website states: “In the AnchoringVR scenario patients select or create visual expressions of that experience and fuel them with audio recordings of their insights,” explains [Enosis co-founder Agnieszka] Sekula.

Media 119

Media Engineering Healthcare Healthcare 119

MedCity News

FEBRUARY 4, 2024

In 2023, prescription drug costs rose by 8.4%, a 31% increase from the prior year. If these dual forces converge, they have the power to bring about a transformative shift that can lower drug spend for millions of American patients. 2024 stands at a critical juncture in the battle against soaring pharmacy costs.

Prescription 303

Prescription Networking Management Pharmaceutical 303

Legacy MEDSearch

DECEMBER 21, 2022

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Press Release by: Inspira Technologies.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Medical 98

European Pharmaceutical Review

DECEMBER 30, 2024

Numerous groundbreaking advances have shown these therapies hold potential to revolutionise how we treat, and potentially cure, many conditions, including for patients with underlying genetic or cellular causes of disease that have been difficult to treat with conventionalapproaches.

Manufacturing 52

Manufacturing Food and Drug Administration Medicine Training 52

Clarify Health

AUGUST 3, 2023

Varied health plan contracts and coverage made it nearly impossible for patients to know ahead of time what they’d be charged for a given service. They must take strategy a step further to consider and address how price transparency will change physician referral patterns and patient choice. Though the rule went into effect on Jan.

Networking 52

Networking Healthcare Healthcare Patients 52

Legacy MEDSearch

DECEMBER 19, 2022

Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. Both the EU and FDA clinical trials will be initiated in Q2 2023 for the purpose of obtaining European and US regulatory approvals respectively in Q1 2024.

Patients 98

Patients Recruitment Physicians Management 98

Pharma Marketing Network

OCTOBER 26, 2022

Our name is derived from our Goal – to serve the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Device and allied industries. Upcoming Dynamic Global Events in 2023: Clinical Research in Latin America Summit – February 9-8, 2023. Facilitate Information Exchange.

Networking 52

Networking Pharma Healthcare Healthcare 52

PM360

MAY 17, 2023

Digital Health Networks , a global leader in healthcare-focused original content production and OTT streaming, announces the inaugural CINEHEALTH International Film and Video Festival where “The CINEHEALTH Awards” will be presented in the following categories: Feature Films, TV episodic series, short-form videos, social media, and TikTok reels.

Networking 52

Networking Pharma Media Healthcare 52

PM360

SEPTEMBER 19, 2023

Digital Health Networks has announced the winners of the first annual Cinehealth International Health and Wellness Film and Video Festival. CINEHEALTH works to bring the community together through patient and HCP engagement using innovative storytelling. The 2023 lineup showcased films from across the globe, including the U.S.,

Networking 59

Networking Doctors Media Pharma 59

European Pharmaceutical Review

MARCH 21, 2024

An additional four years of funding for the Advanced Therapy Treatment Centre ( ATTC ) network is available through this programme. Collaborators include the National Institute for Health and Care Research (NIHR), Innovate UK, the ATTC network and the Cell and Gene Therapy Catapult (CGT Catapult).

Networking 105

Networking Medicine Medical Pharmaceutical 105

European Pharmaceutical Review

APRIL 4, 2024

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

Networking 98

Networking Training Recruitment Healthcare 98

Clarify Health

SEPTEMBER 29, 2023

Healthcare Centers of Excellence are recognized for their commitment to quality, expertise, and the pursuit of the best possible outcomes for patients. They often play a critical role in advancing medical knowledge and improving patient care in specialized areas of healthcare. Feeling inspired?

Networking 52

Networking Healthcare Healthcare Competition 52

PharmExec

APRIL 7, 2023

Kevin Hagan, president and CEO of the PAN Foundation, spoke to PharmExec about the recent IRA changes that impact Medicare, as well as the Foundation's near-term goals.

Networking 52

Networking Pharma Patients 52

Clarify Health

SEPTEMBER 5, 2023

Optimizing provider networks is the number one way to do so. Provider networks are the primary tool for health plans to attract and retain new members while optimizing returns. This makes network design a key factor in any member retention strategy. Payers are constantly looking to improve member outcomes while lowering costs.

Networking 52

Networking Healthcare Provider Healthcare Healthcare 52

Pharmaceutical Technology

JANUARY 10, 2023

The international T1D network TrialNet’s research was instrumental in the FDA’s approval of the first drug to delay T1D in at-risk people. The approval of Tzield, a first-in-class therapy, adds an important new treatment option for certain at-risk patients,” says an FDA spokesperson.

Patients 98

Patients FDA Medicine Education 98

Clarify Health

JUNE 29, 2023

Clarify Health is leveraging Ideon, the industry’s most accurate and comprehensive provider-network data solution, to improve health plan management, lower costs and promote high-quality healthcare. Health plans can use this intelligence to expedite their decision-making processes for network modeling and optimization.

Networking 52

Networking Competition Insurance Healthcare 52

Clarify Health

JANUARY 23, 2024

from 2023 to 2032 , highlighting a growing demand in today’s business landscape—but also underscoring the need for TPAs in healthcare to distinguish themselves from competitors to attract clients and ensure their ongoing success. Networks must be accessible to all employees and adequate for their needs.

Networking 52

Networking Competition Healthcare Healthcare 52

European Pharmaceutical Review

APRIL 23, 2024

The collaboration strengthens Bristol Myers Squibb’s global network of cell therapy manufacturing facilities The collaboration strengthens Bristol Myers Squibb’s global network of cell therapy manufacturing facilities. Manufacturing of cell therapies is both operationally and technically complex.

Manufacturing 96

Manufacturing Networking Patients Pharmaceutical 96

pharmaphorum

DECEMBER 16, 2022

17 th March 2023 | JW Marriott Grosvenor House. The PM Society is delighted to announce a brand new, free of charge, category in the PM Society Awards 2023. An event that showcases the best creative work our industry has to offer and an opportunity for networking and celebration attracting around 1000 guests. PM Society Awards.

Networking 52

Networking Healthcare Healthcare Sales 52

European Pharmaceutical Review

DECEMBER 7, 2023

A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.

Networking 98

Networking Medicine Leads Manufacturing 98

Clarify Health

FEBRUARY 13, 2023

At its core, value-based care (VBC) is about improving patient outcomes, enhancing how care is delivered, and understanding when and where care is not needed. Payments are made according to the number of patient encounters. But it’s time to make the transition because the urgency is there — patients are demanding it.

Networking 52

Networking Physicians Patients Transportation 52

Pharmaceutical Technology

JUNE 5, 2023

Avadel Pharmaceuticals has introduced LUMRYZ (sodium oxybate) for commercial use in the US to treat cataplexy (excessive daytime sleepiness, or EDS) in adult patients with narcolepsy. The US Food and Drug Administration (FDA) granted final approval to the therapy in May 2023.

Food and Drug Administration 98

Food and Drug Administration Pharmaceutical Specialization Food 98

PM360

OCTOBER 11, 2023

Healthware to seamlessly integrate with EVERSANA INTOUCH; shifting from established joint venture to scaled global operation With more than 150 employees and multiple offices across Italy, Finland, and the United Kingdom, Healthware will seamlessly merge with EVERSANA’s global agency network, EVERSANA INTOUCH.

Networking 52

Networking Media Healthcare Healthcare 52

Clarify Health

FEBRUARY 13, 2023

At its core, value-based care (VBC) is about improving patient outcomes, enhancing how care is delivered, and understanding when and where care is not needed. As a physician, I believe now is the time for providers and provider groups to embrace VBC.

Networking 52

Networking Physicians Patients 52

European Pharmaceutical Review

FEBRUARY 27, 2024

The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. ” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff.

Manufacturing 105

Manufacturing Food and Drug Administration Food Networking 105

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. In January 2023, VillageMD acquired Summit Health for $8.9

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

MAY 1, 2023

This move will support the expansion of the company’s global cell therapy manufacturing network. In February 2023, results from a Phase III study showed Bristol Myers Squibbs’ Abecma more than tripled progression-free survival for multiple myeloma (MM) patients.

Manufacturing 98

Manufacturing Engineering Networking Patients 98

Clarify Health

AUGUST 8, 2023

This is the third inclusion of Clarify Health in a Gartner report in 2023. San Francisco, CA (August 8, 2023) – Clarify Health , a leading healthcare analytics and value-based payments platform company, today announced its inclusion in the Gartner Hype Cycle for U.S. In the Hype Cycle for U.S. and/or its affiliates in the U.S.

Healthcare 52

Healthcare Healthcare Networking Marketing 52

MedTechVets

OCTOBER 23, 2023

October 23rd, 2023– On October 10th, MedTechVets hosted a Breakfast Networking Panel titled, “Veteran Impact on MedTech” at The MedTech Conference in Anaheim, California. Additionally, our network contains over 5,000 veteran, mentor, and partner company contacts in just 3 years.

Networking 59

Networking Training Medical Patients 59

pharmaphorum

DECEMBER 16, 2022

The positive opinion for etranacogene dezaparvovec – which was approved as Hemgenix by the FDA last month – raises the prospect of the first one-time therapy in the EU for the bleeding disorder, which affects around 1 in 50,000 of the population, according to the European Haemophilia Network (EUHANET).

Medicine 127

Medicine Prospecting Networking Marketing 127

Pharma Marketing Network

DECEMBER 8, 2022

Upcoming Informa Connect Events: Speaker Programs Summit – February 27-March 1, 2023. Pharma Forum – March 19-22, 2023. PAP – Patient Assistance & Access Programs – March 20-22, 2023. Hub and Specialty Pharmacy Models East – March 20-22, 2023.

Government 40

Government Networking Pharma Pharmaceutical 40

pharmaphorum

JUNE 30, 2022

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.

Patients 65

Patients Recruitment Transportation Healthcare 65

Pharmaceutical Technology

MAY 1, 2023

Additionally, the transaction will offer a foundation of ophthalmology focused capabilities, including expansive experts’ network in the ophthalmology field, a multi-faceted commercial team, and the infrastructure and experience to drive the combined ophthalmology business further.

Food and Drug Administration 111

Food and Drug Administration Pharma Food Networking 111

Legacy MEDSearch

MAY 1, 2023

The results were featured in the late-breaking session ( LBA01-05 ) at the American Urological Association (AUA) 2023 Annual Meeting in Chicago on Sunday, April 30 th. Moreover, the patient-centric nature of the therapy that facilitates individually tailored treatment, resulted in an increasing improvement in UUI over time with 91.6%

Patients 52

Patients Medical Safety Recruitment 52

Clarivate

DECEMBER 6, 2022

healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. states and the United Kingdom and sees more than 35 million patient encounters per year.

Networking 52

Networking Healthcare Healthcare Competition 52

pharmaphorum

OCTOBER 14, 2022

In this article, Research Partnership reviews why the path to commercialisation for the half a dozen approvals in Europe over the last few years has not been smooth, and shares feedback gathered from our payer network on the outlook for gene therapy market access in Europe, especially considering the shift to more prevalent diseases.

Medicine 93

Medicine Marketing Networking Manufacturing 93